SWHR Comments on FDA Guidance on Pregnant Women in Clinical Trials Posted on August 8, 2018 by Melissa Laitner - Resource
SWHR Letter on Prioritization of Diagnostic Reform Posted on August 8, 2018 by Melissa Laitner - Resource
SWHR Calls for Oversight on Clinical Laboratory Diagnostics Posted on May 9, 2018 by Melissa Laitner - Resource
SWHR Contributes to Patient-Focused Drug Development Workshop Posted on February 16, 2018 by Melissa Laitner - Resource
SWHR Supports Continuation of FDA User Fee Programs Posted on May 22, 2017 by Emily Ortman - Resource
